Shorter hospital stays in epistaxis patients with atrial fibrillation when taking rivaroxaban or apixaban versus phenprocoumon

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.3K citations · Full text

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.8K citations · Full text

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters et al. · CHEST Journal · 2009 · 6.6K citations · Full text

Thrombosis, Venous Thrombosis, Cardiovascular Epidemiology +14

Antithrombotic Therapy for VTE Disease

Clive Kearon, Elie A. Akl, Joseph Ornelas et al. · CHEST Journal · 2016 · 4.7K citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +5

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat et al. · CHEST Journal · 2010 · 4.4K citations · Full text

Acute Myocardial Infarction, Thrombosis, Stroke +16